These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 11118795)

  • 41. Visual field constriction on vigabatrin.
    Prescrire Int; 2000 Feb; 9(45):210-1. PubMed ID: 11503799
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Treatment of West syndrome with vigabatrin: clinical and electroencephalographic evaluation of 13 patients].
    Henriques-Souza AM; Ataide Junior L; Laurentino SG
    Arq Neuropsiquiatr; 2007 Mar; 65(1):144-49. PubMed ID: 17420838
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Drug-choice in management of West syndrome (infantile spasms): Early ACTH treatment may offer a better prognostic outcome.
    Jaseja H
    Med Hypotheses; 2008; 70(1):197-8. PubMed ID: 17590279
    [No Abstract]   [Full Text] [Related]  

  • 44. Vigabatrin versus ACTH as first-line treatment for infantile spasms: a randomized, prospective study.
    Vigevano F; Cilio MR
    Epilepsia; 1997 Dec; 38(12):1270-4. PubMed ID: 9578521
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Proposals for the treatment of children with West's syndrome].
    Herranz JL; Argumosa A
    Rev Neurol; 2000 Sep 16-30; 31(6):578-83. PubMed ID: 11055064
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Current problems of treatment for infantile spasms].
    Oguni H; Sugai K
    No To Hattatsu; 2010 Mar; 42(2):144-6. PubMed ID: 23858600
    [No Abstract]   [Full Text] [Related]  

  • 47. Vigabatrin therapy for infantile spasms: review of major trials in Europe, Canada, and the United States; and recommendations for dosing.
    Carmant L
    Acta Neurol Scand Suppl; 2011; (192):36-47. PubMed ID: 22061179
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evidence-based guideline update: medical treatment of infantile spasms. Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.
    Go CY; Mackay MT; Weiss SK; Stephens D; Adams-Webber T; Ashwal S; Snead OC; ;
    Neurology; 2012 Jun; 78(24):1974-80. PubMed ID: 22689735
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adrenocorticotropic hormone for the treatment of West Syndrome in children.
    Shumiloff NA; Lam WM; Manasco KB
    Ann Pharmacother; 2013 May; 47(5):744-54. PubMed ID: 23606552
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of infantile spasms.
    Haines ST; Casto DT
    Ann Pharmacother; 1994 Jun; 28(6):779-91. PubMed ID: 7919570
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Therapy of infantile spasms: new opportunities and emerging challenges.
    Mikati MA; Cornett KM
    Epilepsy Behav; 2010 Apr; 17(4):571-3. PubMed ID: 20097137
    [No Abstract]   [Full Text] [Related]  

  • 52. The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial.
    Lux AL; Edwards SW; Hancock E; Johnson AL; Kennedy CR; Newton RW; O'Callaghan FJ; Verity CM; Osborne JP
    Lancet; 2004 Nov 13-19; 364(9447):1773-8. PubMed ID: 15541450
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Managing epilepsy in tuberous sclerosis complex.
    Thiele EA
    J Child Neurol; 2004 Sep; 19(9):680-6. PubMed ID: 15563014
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of Time to Clinical Remission With Sustained Resolution in Children With New-Onset Infantile Spasms.
    Yuskaitis CJ; Mytinger JR; Baumer FM; Zhang B; Liu S; Samanta D; Hussain SA; Yozawitz EG; Keator CG; Joshi C; Singh RK; Bhatia S; Bhalla S; Shellhaas R; Harini C;
    Neurology; 2022 Nov; 99(22):e2494-e2503. PubMed ID: 36038267
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adrenocorticotropic hormone and vigabatrin treatment of children with infantile spasms underlying cerebral palsy.
    Zafeiriou DI; Kontopoulos EE; Tsikoulas IG
    Brain Dev; 1996; 18(6):450-2. PubMed ID: 8980841
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recent advances in the pharmacotherapy of infantile spasms.
    Riikonen R
    CNS Drugs; 2014 Apr; 28(4):279-90. PubMed ID: 24504827
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of infantile spasms.
    Hancock E; Osborne J; Milner P
    Cochrane Database Syst Rev; 2003; (3):CD001770. PubMed ID: 12917912
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vigabatrin Therapy for Infantile Spasms in a Case of Cardiofaciocutaneous Syndrome with Cardiac Hypertrophy Developing during Adrenocorticotropic Hormone Treatment.
    Hatori T; Sugiyama Y; Yamashita S; Hirakubo Y; Nonaka K; Ichihashi K
    J Nippon Med Sch; 2016; 83(4):167-71. PubMed ID: 27680485
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effectiveness of vigabatrin in west syndrome associated with tuberous sclerosis].
    Ando N; Fujimoto S; Ishikawa T; Kobayashi S; Hattori A; Ito T; Togari H
    No To Hattatsu; 2010 Nov; 42(6):444-8. PubMed ID: 21077355
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Randomized trial of vigabatrin in patients with infantile spasms.
    Elterman RD; Shields WD; Mansfield KA; Nakagawa J;
    Neurology; 2001 Oct; 57(8):1416-21. PubMed ID: 11673582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.